CHU de Strasbourg - Nouvel Hopital Civil

Strasbourg 67091

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Renal Cell Carcinoma (RCC), UC (Urothelial Cancer)

Studies at this site

• Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302) — Completed
• Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307) — Completed
• A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma — Completed